RESUMO
Hospital rehabilitation of patients with myocardial infarction was conducted according to the model worked out by the Institute of Cardiology in Warsaw and modified at the Department of Cardiology of the Medical Academy in Lublin. According to their clinical condition, the patients were divided into 3 groups. Group A comprised patients with extensive myocardial infarction and complications; duration of hospital stay was 28 days. Group B included patients with extensive infarction without complications; hospital stay was 21 days. Group C included patients with limited myocardial necrosis and a mild course of the disease, and duration of stay of 14 days. Out of 1000 patients with myocardial infarction 134 (13.4%) died within the first 4 days after admission, i.e. before the beginning of rehabilitation treatment; 56 (5.6%) died during rehabilitation. The group of patients undergoing rehabilitation treatment comprised 866 patients (86.6%), including 382 (44.1%) in group A, 404 (46.6%) In group B, and 80 (9.3%) in group C. The mean duration of hospital stay of all patients with myocardial infarction was 24.3 days; in 80 cases (9.9%) it was 14 days, in 397 cases (49.0%) 21 days, and in 236 cases (29.1%) 28 days. In 97 cases (12.0%) hospitalization was longer than 28 days. Work was resumed by 30% of white and blue collar workers and 89.5% or farmers within the productive age groups.
Assuntos
Infarto do Miocárdio/reabilitação , Adulto , Idoso , Exercícios Respiratórios , Terapia por Exercício , Feminino , Hospitalização , Humanos , Unidades de Terapia Intensiva , Tempo de Internação , Masculino , Pessoa de Meia-IdadeRESUMO
Long-term treatment with anticoagulants (Sintrom, Suncumar) was applied in 300 cases of myocardial infarction and 106 cases of coronary heart disease without infarction aged 31 to 70 years over periods ranging from one to six years. The control group comprised 347 patients with myocardial infarction and 195 patients with coronary heart disease without infarction in the same age range who were not treated with Syncumar because of contraindications. Treatment with Syncumar was started on the first day at hospital and was continued after discharge from the hospital on an outpatient basis. The level of prothrombin was kept within the range of 35-45%. In the Syncumar treated group the mortality in patients with myocardial infarction was 8.0% and in the control group it was 20.5%. In the Syncumar treated group the incidence of repeated infarctions was 12.7% and in the controls it was 33.1%. On the other hand, no effects of Syncumar on the mortality of patients with chronic coronary heart disease without infarction was observed.
